SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037737
Filing Date
2020-08-06
Accepted
2020-08-06 16:11:41
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20200630.htm   iXBRL 10-Q 2236198
2 EX-10.4 kura-ex104_31.htm EX-10.4 15396
3 EX-31.1 kura-ex311_7.htm EX-31.1 17444
4 EX-31.2 kura-ex312_6.htm EX-31.2 17254
5 EX-32.1 kura-ex321_9.htm EX-32.1 9544
  Complete submission text file 0001564590-20-037737.txt   6402061

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20200630.xsd EX-101.SCH 39280
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20200630_cal.xml EX-101.CAL 43425
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20200630_def.xml EX-101.DEF 102055
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20200630_lab.xml EX-101.LAB 286810
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20200630_pre.xml EX-101.PRE 207480
11 EXTRACTED XBRL INSTANCE DOCUMENT kura-10q_20200630_htm.xml XML 1128410
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 201081728
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences